Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Merck & Co. continues to investigate 5alpha-reductase inhibitors

Sep. 20, 1996

Development of VML-252 progresses

Sep. 13, 1996

Cimetidine for treatment of interstitial cystitis

Sep. 6, 1996

Darifenacin for urge incontinence

Sep. 6, 1996

Potential use for YM-934 in bladder hypersensitivity

Sep. 6, 1996

Urethral insert approved for female stress incontinence

Sep. 6, 1996

Finasteride clinical utility continues to be debated

Sep. 6, 1996

Potential BPH therapy from Glaxo Wellcome

Sep. 6, 1996

5alpha-Reductase inhibitors for BPH

Sep. 6, 1996

Expanded H-BIG clinical development program announced

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...